HM10760A or placebo

DRUG2 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

Healthy

Phase 1

A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects

CompletedNCT01013064

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2009-11-30End: 2011-01-31Updated: 2014-02-07

A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects

CompletedNCT01030315

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2009-10-31End: 2011-01-31Updated: 2014-02-26